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Microfluidic Encapsulation Supports Stem Cell Viability,
Proliferation, and Neuronal Differentiation
Lorena Hidalgo San Jose, PhD,1,2 Phil Stephens, PhD,2 Bing Song, PhD,2 and David Barrow, PhD1
Stem cell encapsulation technology demonstrates much promise for the replacement of damaged tissue in several
diseases, including spinal cord injury (SCI). The use of biocompatible microcapsules permits the control of stem
cell fate in situ to facilitate the replacement of damaged/lost tissue. In this work, a novel customized microfluidic
device was developed for the reproducible encapsulation of neural stem cells (NSCs) and dental pulp stem cells
(DPSCs) within monodisperse, alginate-collagen microcapsules. Both cell types survived within the microcapsules
for up to 21 days in culture. Stem cells demonstrated retention of their multipotency and neuronal differentiation
properties upon selective release from the microcapsules, as demonstrated by high proliferation rates and the
production of stem cell and neuronal lineage markers. When cell-laden microcapsules were transplanted into an
organotypic SCI model, the microcapsules effectively retained the transplanted stem cells at the site of implan-
tation. Implanted cells survived over a 10 day period in culture after transplantation and demonstrated commitment
to a neural lineage. Our device provides a quick, effective, and aseptic method for the encapsulation of two
different stem cell types (DPSCs and NSCs) within alginate-collagen microcapsules. Since stem cells were able to
retain their viability and neural differentiation capacity within such microcapsules, this method provides a useful
technique to study stem cell behavior within three-dimensional environments.
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Introduction
Most of the differentiated cells in adult tissues have arelatively short life span and are continuously re-
placed by new cells generated from stem/progenitor cells. In
the adult mammalian organism, stem cells are found in al-
most all tissues and play a key role in maintaining cell
genesis and renewal in different tissues and organs during
the life span of the animal as part of the natural aging
process, or after cell loss due to injury or disease.1
One of the main differences between embryonic and adult
stem cells is their ability to differentiate into different cell
types; that is, their potency. While embryonic stem cells
(ESCs) are pluripotent, adult stem cells are multipotent or
unipotent, in that their differentiation potential is more re-
stricted and depends on their tissue of origin.2 However, re-
cent studies have proved that these tissue-specific stem cells
are able, under suitable conditions, to ‘‘transdifferentiate’’
toward a wider range of cell types, regardless whether these
cells derive from different germ layers.3 These observations
open a new spectrum of possibilities for adult stem cells to
be used in regenerative medicine.
Adult stem cells can be found in the majority of tissues
within the organism. Among these tissues, the bone marrow
is the most widely used source for the isolation of stem cells,
which can be subsequently expanded in vitro.4 Other sources
of adult stem cells include adipose tissue,5 skeletal muscle,6
and skin.7 In 2000, Gronthos et al. described a clonogenic
population of cells within the dental pulp that demonstrated
high proliferative potential and tissue regeneration capabili-
ty.8 In 2004, Nosrat et al. reported that dental pulp stem cells
(DPSCs) could acquire a neuronal-like morphology and
neuronal protein expression profile in vitro.9 Furthermore, we
have also demonstrated the potential of these cells to differ-
entiate into neuronal-like cells, as part of a preliminary study
investigating repair of spinal cord injury (SCI).10
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The main advantage of DPSCs over other adult stem cells
is that they can be isolated through relatively noninvasive
procedures. Healthy adult teeth, especially wisdom teeth,
are often extracted during orthodontic treatment, while
deciduous teeth are naturally shed in childhood. Dental pulp
can then be excavated and cryogenically preserved. DPSCs
can subsequently be isolated from such tissue, following
thawing, with no detrimental effects in viability, prolifer-
ation, or differentiation.11 This has led to the founding of
tissue banks that serve as stores of patient-matched pro-
genitor cell samples ready to be accessed if and when re-
quired in the future.12
Although stem cell therapy represents a promising tech-
nique in tissue repair and regenerative medicine, there are
still several drawbacks that need to be addressed. In a
similar manner to organ transplantation, stem cell therapy
requires the use of immunosuppressants to maximize cell
viability, survivability and hence, efficacy.13 Furthermore, it
is difficult to control end-stage cell fate within an organism,
where the integration of the transplanted cellular material is
challenging and difficult to achieve. To overcome these
problems, researches have attempted to immobilize stem
cells within biocompatible materials, such as hydrogels.14 A
derivation of this is the encapsulation of the cells in
biomaterial-based microcapsules, which permits the control
of cell migration, differentiation, and tissue integration.15–17
Thus, the microcapsules provide the cells with a three-
dimensional (3D) extracellular matrix environment that al-
lows for a better control of cell parameters.18 Among the
polymers used for cell encapsulation, alginate is the most
commonly used due to its biocompatibility and relatively
mild gelling conditions.19 However, it has been reported that
alginate does not promote cell adhesion, a process that plays
a key role in survival and function of many cell types.20
Therefore, alginate can be combined with collagens, such as
type I collagen.21,22
Encapsulating techniques have been improved over the
last few years, especially using microfluidic devices, and
can enable the production of monodisperse droplets. This
accurate control of capsule size can allow for the precise
allocation of cells per microcapsule, and hence clinical
delivery dose.18 Most of the studies on cell encapsulation
use droplet extrusion methods, where cells are mixed with
the appropriate polymer and then extruded through a nee-
dle, forming droplets that are collected in a gelling bath.23
However, the use of microfluidics allows for the formation
of highly monodisperse microbeads, which can be gelled
in situ, thereby critically reducing their production times.24
We hypothesize that the ability to successfully encapsulate
stem cells with neural potential, using microfluidic techniques,
would enable the future transplantation of such cell-based
constructs into the injured spinal cord soon after injury, mini-
mizing scar formation and enhancing host-tissue integration.
Therefore, we have individually encapsulated DPSCs and
neural stem cells (NSCs) within an alginate-collagen scaf-
fold, using a novel customized microfluidic device.
We have demonstrated that the viability of the cells
within the scaffold was maintained over extended time pe-
riods and, upon release, they maintained their proliferative
and neuronal differentiation potential. The transplantation of
the encapsulated cells in an organotypic model of SCI
permitted the retention of the cells at the implantation site,
demonstrating the significant benefits of using biomaterials
to direct cell location within the host. After 10 days in situ,
cells expressed neural markers, showing that DPSCs
maintain their neural potential within the alginate-collagen
microcapsules in the ex vivo SCI model.
Materials and Methods
Animals
Twenty-one to 28 day old C57/Bl6 mice utilized for
spinal cord tissue harvest were obtained from Charles River
Laboratories, UK and maintained at the Joint Biological
Services Unit at Cardiff University, Cardiff, UK. Mice were
sacrificed by CO2 asphyxiation in accordance with Schedule
1 of the Animals (Scientific Procedures) Act 1986.
Cell culture
Neural stem cells. NSCs were isolated from the cortex
of E14 C57BL/6 mice as previously described.25 Cells were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM)/Ham’s F12 (1:1) containing 2.5mM L-glutamine
and 15mM HEPES buffer (Life Technologies, UK) sup-
plemented with 1% (v/v) penicillin/streptomycin, 2% (v/v)
B27 supplement (Life Technologies), 20 ng/mL basic fi-
broblast growth factor (bFGF), 20 ng/mL epidermal growth
factor (EGF) (both Peprotech, UK), and 10mg/mL insulin-
transferrin-sodium selenite supplement (ITSS) (Roche Life
Science, UK). NSCs were cultured as floating neurospheres
with half medium changes performed every 2 days. Neuros-
pheres were subcultured every 6 days using accutase (Life
Technologies) to digest aggregates into single cells.
Dental pulp stem cells. DPSCs were isolated from the
incisors of 21–28 day old C57BL/6 mice as described by
Young et al.10 Cells were cultured in a-modification Minimum
Essential Medium containing 2mM L-glutamine, ribonucleo-
sides, and deoxyribonucleosides (Life Technologies). The
medium was supplemented with 1% (v/v) penicillin/strepto-
mycin, 20% (v/v) heat-inactivated fetal bovine serum (FBS)
(Life Technologies), and 100mM L-ascorbic acid 2-phosphate
(Sigma-Aldrich, UK). Medium was changed every 2–3 days
until cells reached 80–90% confluence. Upon reaching con-
fluence, cells were dissociated by adding 0.25% (v/v) trypsin-
EDTA (Sigma-Aldrich).
Encapsulation of stem cells within alginate-collagen mi-
crocapsules. NSCs and DPSCs were individually re-
suspended in a polymer solution containing 2% (w/v)
medium viscosity alginic acid (Sigma-Aldrich), 50mM
microcrystalline precipitated CaCO3 (Speciality Minerals,
Birmingham, UK), and 2mg/mL type I collagen (First
Link, UK) at a density of 1 · 106 and 1 · 107 cells/mL,
respectively. Cells were encapsulated within alginate-
collagen microcapsules of 440– 3 mm diameter with a
customized microfluidic device coupled with controllable
syringe pumps (KD Scientific, UK) (Fig. 1A, B), for fluid
delivery. Microcapsules were then collected in tubes con-
taining prewarmed culture medium and, after washing with
phosphate-buffered saline (PBS), they were suspended in
fresh culture medium and transferred to the incubator (37C,
5% CO2).
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Viability and proliferation
Trypan blue exclusion assay. Alginate-collagen micro-
spheres were dissolved after a 5min incubation at 37C with
55mM sodium citrate, followed by an additional 5min in-
cubation at 37C with 1% (w/v) type I collagenase (both
Sigma, UK), thereby releasing the cells. Cells were then
centrifuged (100 g for NSCs and 400 g for DPSCs), su-
pernatant removed, and resuspended in culture medium.
Cell viability was estimated using trypan blue exclusion
assay. Since NSCs grew in neurospheres, such aggregates
were also digested by a 5min incubation at 37C with ac-
cutase before cell counting.
Live/dead assay and laser scanning confocal microscopy.
Encapsulated cells were incubated with a solution contain-
ing 2 mM calcein and 2mM ethidium homodimer-1 (EthD-1)
(Life Technologies) in PBS for 30min at 37C. Subsequently,
the distribution of live cells (green) and dead cells (red) was
visualized using a Leica SP5 Confocal Microscope and Leica
Application Suite Advanced Fluorescence (LAS AF) imaging
software. Images of encapsulated cells were acquired from
confocal Z scans over a depth of 400mm. Acquired images
were processed and overlapping images merged using freely
available ImageJ software (https://imagej.nih.gov/ij/).
CellTrace Far Red staining for proliferation analysis by
flow cytometry. DPSCs were stained with CellTrace Far
Red Cell Proliferation Kit following the manufacturer’s
instructions (Life Technologies). Briefly, a stock solution of
staining reagent was added to the cell suspension to give a
concentration of 1 mM, and cells were incubated for 20min
at 37C, in the dark. Culture medium containing 10% (v/v)
FBS was added for 5min to quench any free dye in solution.
Cells were washed twice and seeded in flasks or encapsu-
lated for further analysis using a FACSCanto flow cytometer
(BD Biosciences, UK) coupled with HeNe 633 nm laser.
Red fluorescence emission from CellTrace Far Red labeled
cells (660/20 nm long pass filter) were measured. These data
were then analyzed with FlowJo Version 10.2 software.
Inhibition of cell proliferation with mitomycin C. Negative
controls of proliferation were prepared by treatment of DPSCs
with mitomycin C according to manufacturer’s instructions.
Briefly, mitomycin C (Fisher Scientific, UK) was added to
flasks containing 80–90% confluent DPSCs and culture me-
dium to achieve a 10mg/mL final concentration. Cells were
then incubated for 3 h at 37C in a humidified incubator with
5% CO2. Mitomycin C was removed and, after two washes
with PBS, cells were trypsinized and seeded in flasks.
MTT assay. Cells were released from the microcapsules
(see above), seeded in 96-well plates at a cell seeding density of
1000 cells/well, and allowed to settle down overnight. Twenty
microliters of 5mg/mL 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) solution (Sigma-
Aldrich) were added to each well, and incubated for 4 h at
37C/5%CO2.Culturemediumwas then removed and 150mL
of dimethyl sulfoxide was added to each well to dissolve any
formed formazan crystals. Plates were incubated for an ad-
ditional 30min to allow the precipitate to dissolve completely.
Absorbance was subsequently measured at a wavelength of
540 nm (FLUOstar Omega microplate reader; BMG Lab-
tech). Before NSC seeding, plates were precoated (24 h) with
50 mg/mL poly-d-lysine (PDL) and 20 mg/mL laminin.
Apoptosis Tunel assay. Apoptotic nuclei in tissue sec-
tions were identified using the Click-iT Plus Tunel Assay
(Thermo Fisher Scientific, UK) according to manufacturer’s
instructions. Briefly, tissue sections were incubated with 1·
Proteinase K solution in PBS for 15min. Samples were then
incubated with EdUTP and TdT enzyme for 60min at 37C.
This was removed and Alexa Fluor 594 dye containing
copper protectant was then added to the tissues and incu-
bated for 30min at 37C, protected from light. This solution
was removed and after washing with PBS, tissues were
mounted onto glass cover slips using mounting media sup-
plemented with DAPI stain (VectorLabs, UK). Images of
tissue sections were acquired with Deltavision imaging
software with X/Y/Z multiple position recording (Applied
Precision).
Neuronal differentiation
NSCs neuronal differentiation. Encapsulated NSCs were
released from the microcapsules 21 days after encapsulation
and seeded at a density of 10,000 cells/cm2 on 50mg/mL
PDL/20mg/mL laminin-coated plates in DMEM/F12 (1:1)
containing 2mM L-glutamine and HEPES buffer, 1% (v/v)
penicillin/streptomycin, 2% (v/v) B27 supplement, 20 ng/mL
bFGF, 20ng/mL EGF, and 10mg/mL ITSS. Neuronal dif-
ferentiation was induced as previously described.26 Briefly,
when cells reached 80–90% confluence, growth factors were
gradually removed by half media changes every other day,
for up to 10 days with growth factor-free culture medium.
DPSCs neuronal differentiation. Encapsulated DPSCs
were released from the microcapsules 21 days after encap-
sulation and seeded at a density of 10,000 cells/cm2 on
10 mg/mL PDL/20 mg/mL laminin-coated plates. DPSCs
were subjected to neuronal differentiation as previously
described.10 Briefly, DPSCs were cultured in DMEM/F12
(1:1) containing L-glutamine and HEPES buffer, 1% (v/v)
penicillin/streptomycin, 2% (v/v) B27 supplement, 20 ng/
mL bFGF, 20 ng/mL EGF, and 10 mg/mL ITSS. After 5 days
in culture, cells were washed with PBS and medium re-
placed with Neurobasal medium supplemented with 1% (v/v)
penicillin/streptomycin, 2mM L-glutamine, 1· non-essential
amino acids (Sigma-Aldrich), 10 ng/mL nerve growth factor,
10 ng/mL brain derived neurotrophic factor, and 10 ng/mL
neurotrophin-3 (all Peprotech).
Immunocytochemical staining. Cells and tissues were
fixed with 4% (w/v) paraformaldehyde for 30min at room
temperature and then permeabilized in 0.1% (v/v) Triton
X-100 for 30min at room temperature. Nonspecific antibody
binding was blocked by incubating in 5% (w/v) bovine serum
albumin for 30min. Samples were incubated overnight with
the following primary antibodies: Nestin (10mg/mL; Sigma),
Sox2, Oct4 (10 and 2.5mg/mL, respectively; Abcam, UK), b-
III tubulin, Map2 (both 5mg/mL; Cell Signalling, UK), and
GFAP (2mg/mL; Life Technologies). On the following day,
complementary Alexa Fluor 488- and 594-conjugated sec-
ondary antibodies (both 4mg/mL; Life Technologies) were
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applied. Glass coverslips weremounted usingmountingmedia
supplemented with DAPI stain (VectorLabs) and preparations
imaged with Deltavision imaging software with X/Y/Z mul-
tiple position recording (Applied Precision).
Dissection and preparation of murine spinal cord ex-
plants. Spinal cord slice cultureswere prepared as previously
described.27 Briefly, from the 21–28 day old C57BL/6 mice
complete spinal cords were dissected on ice. Cords were then
washed twice in PBS supplemented with 1% (v/v) penicillin/
streptomycin. Cords were cut with surgical blades on ice into
*1 cm long sections. These were transferred to the centers of
35mm tissue culture dishes with the dorsal area facing upward.
An injury was induced on the center of each section by re-
moving part of the tissue with a scalpel. The resulting damage
area was 2.5mm long and 0.5 cm wide, approximately.
Transplantation of encapsulated cells in ex vivo SCI
model. To allow for easy identification of transplanted cells, a
mixed population of NSCs and fibronectin-adherent DPSCs
were isolated as described before from transgenic mice ex-
pressing GFP. Three different cell types were encapsulated
within alginate-collagen microcapsules: (1) undifferentiated
DPSCs, (2) neuronal predifferentiated DPSCs, and (3) undif-
ferentiated NSCs. Neuronal predifferentiated DPSCs were
cultured in NSC growth medium for 5 days before encapsula-
tion.Microcapsules were then transplantedwith forceps into the
ex vivo SCImodel previously prepared. Six microcapsules were
transplanted for each experimental condition and sealed in po-
sition with 30mL of Matrigel (BD Biosciences). Spinal cords
were cultured with DMEM/F12 medium containing 25mM
HEPES buffer supplemented with 1% (v/v) penicillin/strepto-
mycin and 20% heat-inactivated FBS (all Life Technologies)
for up to 10 days, with medium changes every other day.
Fluorescence quantification. Fluorescence quantification
was performed with ImageJ software (https://imagej.nih.gov/
ij/), utilizing Huang’s algorithm to stablish the threshold to
define the regions of interest. Mean fluorescence intensity
per GFP-expressing cell was calculated.
FIG. 1. (A) Schematic representation of cell encapsulation within alginate-collagen microcapsules. The customized
microfluidic device included one middle inlet for the introduction of the polymer solution containing the cell suspension.
Microcapsules were produced by the shear force generated by the continuous phase formed by a laminar flow composed of
MO and AA in mineral oil. (B)MO phase (red) acted as a shielding phase to prevent quick alginate gelation at the junction.
Scale bar = 800 mm. (C) Highly monodisperse cell-laden alginate-collagen microcapsules of 440– 3 mm were produced with
the customized microfluidic device. (D) Encapsulated NSCs growing in the form of neurospheres inside the alginate-
collagen microcapsules (white arrows). (E) DPSCs were maintained as single cells within the microcapsules. Scale
bars = 100mm. AA, acetic acid; DPSC, dental pulp stem cell; MO, mineral oil; NSC, neural stem cell.
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Statistics
Data are represented as mean – standard error of the mean
(SEM). Statistical significance was determined by Student’s
t-test. p < 0.05 was considered statistically significant.
Results
Stem cells can be effectively encapsulated
in alginate-collagen microspheres
The production of stem cell-laden alginate-collagen mi-
crocapsules was carried out utilizing a flow-focusing device
fabricated on a polytetra-fluoroethylene disc (Fig. 1A, B).
The customized microfluidic device included one middle
inlet for the introduction of the polymer solution containing
the cell suspension. Microcapsules were produced by the
shear force generated by the continuous phase formed by a
laminar flow composed of mineral oil and acetic acid in
mineral oil. Uncontrolled alginate gelation was prevented by
the mineral oil (Fig. 1B; red) acting as a shielding phase.
Highly monodisperse cell-laden alginate-collagen micro-
capsules of 440 – 3 mm (n = 30) were produced (Fig. 1C).
The two stem cell types encapsulated demonstrated dif-
ferent behaviors within the alginate-collagen microcapsules.
NSCs formed aggregates within the microcapsules (Fig. 1D).
Small cell aggregates were visible around 3 days after en-
capsulation, which increased in size along the culture period
(21 days). However, DPSCs resided within the microcapsules
as single cells (Fig. 1E). Few cells migrated outside micro-
capsules and attached on flask surface around 10 days after
encapsulation (data not shown).
Stem cells survive microfluidic encapsulation
Stem cell viability within the capsules was assessed by
trypan blue staining after the release of the cells from the
beads (Fig. 2A). The viability of the encapsulated NSCs
increased over the 21-day test period from 75% to around
90%. Conversely, a slight decrease in viability was dem-
onstrated for the encapsulated DPSCs, although *70% of
cells remained viable over the time course.
To confirm these findings in situ, encapsulated NSCs and
DPSCs were stained with calcein and EthD-1 at day 1 and
21 postencapsulation (Fig. 2B). Confocal laser scanning
microscopy images of the cells were acquired over a Z-scan
depth of 400mm. The appearance of both NSCs and DPSCs
differed within the microcapsules. NSCs increased in
number over the period of assessment and became aggre-
gated into neurosphere-like structures. Furthermore, few
dead cells (red) were observed.
For the DPSCs, however, cell number was relatively con-
stant but the number of nonviable cells (red) increased, in
agreement with the trypan blue viability results. Interestingly,
throughout the time course of the investigation there was little
evidence of the cells spreading out and attaching to the sur-
rounding 3D scaffold within the bead. The random distribu-
tion of dead cells (red) for both cell types suggested an
appropriate scale of the alginate-collagen microcapsules and
that nutrient diffusion/waste build-upwas not a limiting factor.
DPSCs do not proliferate within
alginate-collagen microcapsules
NSCs proliferation within the microcapsules was con-
firmed by an increase in the number of viable cells by trypan
blue exclusion assay and the observation of large cell ag-
gregates by laser scanning confocal microscopy. However,
the lack of proliferation by DPSCs required further confir-
mation. To this end, DPSCs were stained with CellTrace Far
Red Cell Proliferation Kit and analyzed with flow cytome-
try. Before labeling, one group of cells was treated with
FIG. 2. (A) Cell viability was estimated by trypan blue exclusion assay. The number of viable NSCs encapsulated within
alginate-collagen microcapsules increased over the period tested (triangles). However, the viability of encapsulated DPSCs
decreased after the 3 week period (dots). Data shown are mean – SEM (n = 3) ***p < 0.001 (vs. first point). (B) Confocal
images of encapsulated stem cells within alginate-collagen microspheres stained with calcein and EthD-1. Green fluores-
cence is emitted from live cells, whereas red fluorescence is emitted from dead cells. Increase in NSCs viability was
confirmed by the formation of large, green cell aggregates within the microcapsules. The viability of encapsulated DPSCs
decreased as observed by an increase in the number of red (dead) cells. Scale bars = 100 and 10mm (insets). EthD, ethidium
homodimer; SEM, standard error of the mean.
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mitomycin C to inhibit cell proliferation and then stained
with the CellTrace Kit (+MC; negative control). A second
group of cells was not treated with mitomycin C but labeled
with the CellTrace Kit (-MC; positive control). The third
group of cells was stained and encapsulated within alginate-
collagen microcapsules (sample). Both controls (in form of
cells monolayer) and encapsulated cells were cultured under
standard conditions for up to 7 days and analyzed by flow
cytometry (Fig. 3). Encapsulated cells were released from
microcapsules before analysis.
Untreated monolayer cultures of cells (-MC; positive con-
trol) showed clear cellular proliferation as evidenced by a shift
and fall off of the fluorescent signal as the cells divided over
a period of 7 days and hence ‘‘shared’’ their fluorescentmarker.
Treated monolayer cultures of cells (+MC; negative control)
failed to divide, as demonstrated by a consistent fluorescent
signal. Prestained, encapsulated cells were released from the
microcapsules (sample) after set periods of time in culture and
analyzed. No drop or shift in the fluorescence peak indicated
that the DPSCs did not proliferate within the microcapsules.
Multipotency and neuronal differentiation potential
are maintained after encapsulation
NSCs and DPSCs were released from microcapsules
21 days after encapsulation and their proliferative potential
assessed utilizing an MTT assay. Despite there being little
evidence of proliferation, when the encapsulated DPSCs
were released and then subsequently maintained in culture
there was demonstrable proliferation for both DPSCs and
NSCs (Fig. 4A, B). Indeed, while there were some subtle
individual (time point) differences between encapsulated
and control cells, the proliferative trend between these two
cells types was very similar with distinct proliferation seen
when each was compared with their respective day 1 value
( p< 0.01 and p < 0.001).
With postencapsulated cells able to divide, their neuronal
differentiation potential was next investigated. Encapsulated
cells were liberated from the alginate-collagen microbeads
21 days after encapsulation and then exposed to a neuronal
differentiation protocol. Undifferentiated NSCs demon-
strated a bipolar morphology with rounded bodies (Fig. 4C).
Upon differentiation, cells developed an increased number
of extending processes and connected with adjacent cells.
Undifferentiated DPSCs were typically bipolar and showed
a fibroblastic-like appearance. After the differentiation pro-
tocol, cell bodies adopted a more rounded morphology with
multiple long processes sprouting out forming neuronal-like
connections.
Such a neuronal phenotype was investigated utiliz-
ing immunocytochemical analysis (Fig. 4C). Before and
postdifferentiation, NSCs demonstrated evidence of both
FIG. 3. Study of DPSCs
proliferation within alginate-
collagen microcapsules. Both
controls and samples were
stained with CellTrace Far
Red Cell Proliferation Kit
and analyzed by flow cy-
tometry over a period of
7 days. Mitomycin C treated
cells (+MC) failed to divide
as demonstrated by no de-
crease in the fluorescent sig-
nal. No mitomycin C treated
cells (-MC) demonstrated
cellular proliferation as evi-
denced by a shift and fall off
of the fluorescent signal over
a period of 7 days. No drop
or shift in the fluorescence
peak of encapsulated cells
(sample) indicated that the
DPSCs did not proliferate
within the microcapsules.
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pluripotency markers (Sox2 and Oct4) and mature neu-
ronal markers (b-III tubulin and Map2), suggesting a
heterogeneous population of cells. The clear production of
neuronal-like structures was evident after differentiation.
Before differentiation, DPSCs appeared preneuronal with
pluripotency markers (Sox2 and Oct4) switched on, and
neuronal markers (b-III tubulin and Map2) switched off.
However, postdifferentiation the opposite was demonstrated,
indicating that during the 21-day encapsulation period, these
stem cells retained their ability to differentiate toward a
neuronal-like lineage.
Encapsulated stem cells maintain functionality
in an ex vivo spinal cord slice model
Six microcapsules containing an average of 2700 cells in
total were transplanted into each ex vivo spinal cord slice
culture (Fig. 5A). The addition of Matrigel on the top of the
FIG. 4. (A, B) NSC and DPSC proliferation upon release from alginate-collagen microcapsules. NSCs and DPSCs were
released from microcapsules 21 days after encapsulation and seeded on 96-well plates. MTT proliferation assay was carried
out on days 1, 3, 5, and 7 and absorbance measured at 540 nm. Both cell types (dots) showed similar growth rates to the
nonencapsulated controls (crosses), suggesting that proliferation of cells was not compromised by encapsulation with
alginate-collagen microcapsules. Data are shown as mean – SEM (n = 3) **p< 0.01; ***p < 0.001 (compared to day 1). (C)
Bright field and fluorescence images before and after neuronal differentiation of NSCs and DPSCs. Undifferentiated NSCs
in growth medium show bipolar morphology with rounded bodies. Differentiated NSCs developed cell projections emerging
from cell body, creating connections with adjacent cells. DPSCs before differentiation were typically bi-/tri-polar and
fibroblast-like. After the differentiation protocol, DPSCs cell bodies adopted rounded morphology with multiple long
processes sprouting out forming neuronal-like connections. NSCs and DPSCs were stained with antibodies against Nestin,
Sox2, Oct4, b-III tubulin, and Map2, before and after differentiation. Scale bars = 25 mm.
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beads permitted the improvement of cell engraftment by
sealing the microcapsules at the transplantation site, thereby
avoiding the loss of beads during the culture period and
preventing any potential spread of the injury. After Matrigel
solidification, explants were incubated for fixed periods of
time in culture then fixed, dehydrated, and cryosectioned into
20mm thick slices (Fig. 5B–D). Alginate-collagen capsules
containing GFP DPSCs could be observed in the middle of
the cord, demonstrating the efficacy of Matrigel to retain the
capsules at the site of implantation.
To highlight the benefits of the cell encapsulation tech-
nique for transplantation purposes, a comparison between
the implantation of encapsulated and unencapsulated cells
was carried out. The same number of cells corresponding to
the transplantation of six beads loaded with cells (*2700
cells) were pipetted into the site of injury, re-suspended in
2 mL of culture medium. Matrigel was then added on the top
to seal the injury and to retain the cells at the site of im-
plantation. Tissues were fixed, dehydrated, and sliced into
20 mm slices. Figure 5E and G demonstrate that cells could
be observed with both methods of delivery immediately
after transplantation. However, the longer-term localization
of the cells differed according to the implantation method
utilized. After 10 days, no GFP-positive cells were found at
the injury site when cells were implanted as cell suspension
(nonencapsulated) (Fig. 5F). Conversely, GFP-positive en-
capsulated cells were observed within the capsules at the
injury site 10 days after transplantation (Fig. 5H).
Undifferentiated DPSCs (cell type 1), predifferentiated
DPSCs (cell type 2), and undifferentiated NSCs (cell type 3)
were individually encapsulated and then transplanted into an
organotypic model of SCI. Cell viability was studied both im-
mediately (Day 0) and 10 days after transplantation. Cells were
fixed, dehydrated, and cryosectioned before staining with
Apoptosis Tunel Assay (Fig. 6). All three cell types were
viable at the time of implantation, since no co-expression
of DAPI/GFP/AF 594 was observed (Figure 6A–C). Ten
days after transplantation, a number of apoptotic nuclei were
observed for cell types 1 and 2, as observed by co-expression
of DAPI/AF 594 (Figure 6D and E). However, some en-
capsulated cells were still viable for the three cell types.
Furthermore, NSCs (cell type 3) proliferated within the tissue
and started to form aggregates (Figure 6F). No signs of cell
proliferation were observed for either DPSCs population.
This behavior was similar to that observed in standard culture
of encapsulated cells, where NSCs grew in the form of ag-
gregates, but DPSCs did not proliferate.
All three cell types were encapsulated within alginate-
collagen microcapsules, implanted into ex vivo spinal cord
slices and cultured for up to 10 days. Tissue sections were
fixed at days 0 and 10, dehydrated, and stained with anti-
bodies against Nestin, Map2, and GFAP (Fig. 7). An intense
endogenous staining of GFAP was observed in the spinal
cord cultures, regardless of the cell type or the time point.
However, none of the cell types investigated expressed
GFAP at any time point.
Undifferentiated DPSCs (cell type 1) expressed the neural
progenitor marker Nestin before and after culture within the
section of the spinal cord. On the other hand, Map2, associ-
ated with more mature neuronal phenotypes, was not ob-
served immediately after transplantation, but it was expressed
after 10 days in culture.
For predifferentiated DPSCs (cell type 2) at day 0, Nestin
expression was high and Map2 expression was not observed,
which suggests that the predifferentiated DPSCs hold the
neural stem/progenitor cells property at day 0. This Nestin
FIG. 5. (A) Murine spinal cord was dissected after CO2 asphyxiation. An injury was induced on the dorsal part of the cord.
Encapsulated cells were transplanted at the site of injury and sealed withMatrigel. Scale bar= 500mm. (B) Twenty micrometer
thick frozen section of spinal cord. Scale bar= 500mm. (C, D) Detailed images (dotted square in B) (bright field and fluores-
cence, respectively) showing encapsulated GFP DPSCs within the spinal cord. Scale bars= 100mm. (E) Few unencapsulated
cells could be observed within the tissue directly injected after implantation (white arrows). (F) Ten days postinjection, the
injury site remained devoid of any nonencapsulated cells. (G) Encapsulated cells (dotted circles) were transplanted and visible at
the injury site. (H) Encapsulated cells (dotted circles) were still visible 10 days after transplantation. Scale bars= 100mm.
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FIG. 6. Apoptosis Tunel Assay
of encapsulated cells transplanted
into an ex vivo model of SCI. Co-
expression of DAPI-stained nuclei
(blue), GFP cells (green), and ap-
optotic nuclei (red). Encapsulated
cells from the three conditions
were transplanted and viability was
studied using an Apoptosis Tunel
Assay 0 (A–C) and 10 days (D–F)
after transplantation. Condition 1:
undifferentiated DPSCs (A, D);
condition 2: predifferentiated
DPSCs into neuronal-like cells
(B, E); condition 3: undifferenti-
ated NSCs (C, F). Scale bars =
25 mm. SCI, spinal cord injury.
FIG. 7. Expression of neuronal markers by transplanted cells from the three conditions. (A) Alginate-collagen micro-
capsules individually loaded with the three cell types were implanted in spinal cord slices and cultured for up to 10 days.
Explants were stained with antibodies against Nestin, Map2, and GFAP before (day 0) and after culture (day 10). Scale
bars = 25 mm. Fluorescence quantification of (B) Nestin and (C) Map2 markers. Data shown are mean – SEM, *p< 0.05;
**p < 0.01; ***p < 0.001.
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expression was higher than that observed for undifferenti-
ated cells at day 0, demonstrating that the predifferentiated
DPSCs shows better neuronal differentiation capacity.
However, predifferentiated DPSCs showed a sharply de-
creased Nestin expression at day 10, in contrast with an
elevated Map2 expression at the same time, suggesting a
dominant neuronal differentiation at this time point.
Unlike undifferentiated and predifferentiated DPSCs, un-
differentiated NSCs (cell type 3) stained positively for Nestin
and Map2 at day 0, being Nestin expression higher. This was
reversed at day 10, where Map2 expression was increased.
Discussion
The novel microfluidic method used in our lab permitted
the production of highly monodisperse stem cell microcap-
sules, without the use of surfactants, and were gelled in situ in
a matter of seconds. This rapidity is of considerable impor-
tance in terms of cell viability, since it permitted the quick
transfer of the encapsulated cells into culture medium,
thereby minimizing the risk of cell viability loss due to un-
favorable conditions.
Cell encapsulation technology has been widely applied
to improve grafts in tissue engineering applications, including
bone and cartilage regeneration,28 skin wound repair,29 and
treatment of dental defects.30 Immobilization of cells within
hydrogels permits the accurate delivery of the cells at the injury
site, allowing for a better performance of their therapeutic
effect.15–17 In this article, we investigated the application
of our customized microfluidic device for NSC and DPSC
encapsulation, as part of our ongoing studies into SCI repair.
Cell viability studies demonstrated two different behav-
iors for the NSCs and DPSCs. The viability of NSCs in-
creased over the investigation period, suggesting that cells
proliferated within the alginate-collagen microcapsules.
Laser scanning confocal microscopy showed an increase in
the size of NSCs aggregates, supporting the results obtained
with trypan blue exclusion assay.
Neurosphere growth in standard culture conditions occurs
at a higher rate than that observed in encapsulated NSCs.
Hence, it was deemed that encapsulation did not prevent
proliferation of NSCs, but rather provoked a delay in cell
growth. This delay in NSC proliferation permits maintenance
of a higher cell viability than the conventional neurosphere
culture method, where neurospheres tend to develop necrotic/
apoptotic centers due to mass transport limitations.31 Similar
studies have shown that nonencapsulated ESCs had a higher
net growth rate when compared with encapsulated cells.32
Other investigations on the influence of alginate matrix on
the proliferation of encapsulated NSCs demonstrated that
their growth rate decreased with an increase in the hydrogel
stiffness.33 Thus, proliferation of cells is affected by the
mechanical resistance of the surrounding environment.
Unlike NSCs, DPSCs exhibited little sign of cell pro-
liferation, indeed a decrease in the number of viable cells
was observed. However, cell viability was still encour-
agingly high (*70% of viable cells) up to 21 days after
encapsulation. Interestingly, both bright field and confocal
microscopy images of encapsulated cells showed little
characteristic evidence of adhered cells, as they remained
rounded within the alginate-collagen microspheres. Other
studies on DPSCs immobilized within alginate hydrogels
reported similar results.34,35 Kanafi et al. highlighted the
different morphology of DPSCs depending on the culture
conditions. When these cells were cultured in standard 2D
culture they acquired fibroblast-like shapes, whereas when
the cells were encapsulated within alginate microspheres
they adopted rounded morphologies. The same behavior
has also been observed for olfactory ensheathing cells,
Schwann cells, and mesenchymal stem cells (MSCs)
cultured on alginate hydrogels, where the cells acquired
atypical spherical shapes and their metabolic activities
were inhibited.36,37
DPSC lack of proliferation was further demonstrated by
cell labeling with CellTrace Far Red Cell Proliferation Kit
and analysis with flow cytometry. This finding is opposed to
that reported by Kanafi et al.,35 where an increase in cell
absorbance after addition of MTT reagent was observed
over a period of 10 days in respect of DPSCs encapsulated
within alginate beads. In the method developed by Kanafi
et al., the MTT reagent was directly added to plates where
encapsulated cells were cultured. It is plausible that some of
these cells might have escaped the beads, attached to the
tissue culture surface of the plates and then proliferated (we
have observed similar results for alginate only beads).
However, the CellTrace method used in this work overcame
the issue of potential cell escape (only viable cells directly
isolated from the beads were analyzed) and demonstrated
that DPSCs did not proliferate within alginate-collagen
microcapsules.
Prolonged in vitro culture of viable, quiescent MSCs is
well reported. MSC spheroid culture within collagen gels
supports the maintenance of cell quiescence until regenerative
stimuli were applied.38 Different studies have demonstrated
that MSC spheroid culture prolongs replicative lifespan
and delays cell senescence of MSCs in vitro,39 driving an
increased expression of pluripotency marker genes (Nanog,
Sox2, and Oct4).40,41 A different study on how to extend
lifespan in yeast gives a hint of the potential mechanisms
involved in the behavior of adherent stem cells encapsulated
in low adherence hydrogels. Nagarajan et al. showed that
encapsulated yeast cells within calcium alginate beads and
fed ad libitum ceased to divide, but they maintained >95%
viability over the course of 17 days. Analysis of gene ex-
pression of immobilized yeast cells demonstrated decreasing
transcription of genes that regulate the cell cycle.42
A similar mechanism might take place in non-attached
DPSCs within alginate-collagen microcapsules, where cells
go into cell cycle arrest but continue to be metabolically
active. Since cell aging is related to how many times a cell
divides, controlled inhibition of cell division by encapsu-
lation could allow for the temporal extension of stem cell
lifespan. Hence, it was hypothesized that the alginate-
collagen microcapsules produced here provide the cells
with an artificial ‘‘niche’’ in which DPSCs reside in a
quiescent state. This is like DPSCs residing within the
dental pulp of living organisms, usually remaining quies-
cent when they are within the dental pulps, but responding
quickly after injury.43
The maintenance of the multipotency and neuronal dif-
ferentiation potential of cells after prolonged periods of time
within microcapsules was investigated. Although the be-
havior of NSCs and DPSCs was altered under encapsulation
conditions, upon release from the capsules, cells retained
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stem cell properties, as demonstrated by high growth rates
and the expression of both stem cell and neuronal markers.
Both NSCs and DPSCs developed neuronal-like morpholo-
gies after application of a neuronal differentiation protocol
previously developed in our group.10 Analysis of protein ex-
pression showed that NSCs expressed the neural markers
Nestin, b-III tubulin, and Map2 and the stem cell markers Sox2
and Oct4 before and after differentiation. Co-expression of
Nestin and b-III tubulin has been suggested to be involved in
the formation of cell processes during the differentiation of
NSCs.44 Although no variations in protein expression was re-
ported byNSCs, it was observed that cells developed long axons
and neurites emerging from cell bodies, both creating connec-
tions with adjacent cells and adopting a neuronal morphology.
Expression of Nestin by DPSCs was also observed both
before and after differentiation. However, their behavior
differed from that shown by NSCs in that DPSCs produced
the stem cell markers Sox2 and Oct4 in the undifferentiated
state but not after the differentiation protocol. In contrast,
early stage neuronal markers b-III tubulin and Map2 were
only visible in the differentiated state. DPSCs exhibited a
change in their phenotype toward a neuronal-like morphology.
Cells were typically bi-/tri-polar and fibroblast-like before
differentiation. After the differentiation protocol, DPSC bod-
ies adopted a rounded morphology with multiple long pro-
cesses sprouting out forming neuronal-like connections. These
results are similar to those reported previously in our group in
nonencapsulated DPSCs,10 confirming that the encapsulation
process did not affect DPSC capacity to undergo neuronal
differentiation.
When encapsulated cells were transplanted into an ex vivo
SCI model, it was demonstrated that microcapsules helped
retain the grafted cells at the wound site, since no cells were
found outside the implantation area. However, when cells
were injected as cell suspension, no cells were found at the
injury site after the culture period. The lack of extracellular
matrix at the lesion site, which directs and organizes the
wound healing cells, is one of the mechanisms that inter-
feres with regenerative processes after SCI.45 Hence, stem
cell encapsulation prior implantation into the damaged area
facilitates the integration of transplanted cells.
The survival of the encapsulated cells after transplantation in
the ex vivo model of SCI was studied after 10 days in culture.
Encapsulated cells of three cell types survived throughout the
culture period, as evidenced by limited apoptosis staining.
Neither undifferentiated, nor neuronal predifferentiated DPSCs
showed signs of proliferation, since no increased cellular den-
sity at the site of grafting could be observed. In contrast, NSCs
showed some signs of cell proliferation, as indicated by the
observation of small cell aggregates after the culture period. In
relation to this, it has been demonstrated that immobilized
neural progenitor cells within microfibers showed high prolif-
eration rates after transplantation into an in vivo mouse model
of SCI.46 Conversely, it has been reported that DPSCs do not
proliferate after implantation into the mouse hippocampus but
they stimulate proliferation of endogenous neural cells.47
The neural marker expression of encapsulated cells after
transplantation was investigated using three different cell
types: undifferentiated DPSCs, predifferentiated DPSCs,
and undifferentiated NSCs. It is noteworthy to mention that
none of the cell types investigated expressed GFAP at any
time point. GFAP expression is associated with the forma-
tion of the glial scar after SCI, which has been regarded as
inhibitory of axonal regrowth.48,49
At the time of implantation, undifferentiated and pre-
differentiated DPSCs showed distinct marker profiles. Nestin
expression by predifferentiated DPSCs (cell type 2) was
higher than for undifferentiated DPSCs (cell type 1). None of
the DPSCs demonstrated positive staining for Map2. How-
ever, after 10 days in culture, both DPSC cellular populations
stained positive for the neural markers Nestin and Map2.
Expression of Map2 by undifferentiated cells and pre-
differentiated cells after the culture period suggests that
the local environment provides signals that influence the fate
of stem cells. Hence, transplanted DPSCs could have received
signals from the spinal cord culture microenvironment that
stimulated their differentiation toward neuronal lineages in the
absence of external growth factors in the culture medium.
These results are comparable to those reported by Kira´ly
et al.,50 where neuronally predifferentiated human DPSCs
transplanted into the rat brain in vivo, expressed a number
of neuronal specific markers, including N-tubulin,
Neurofilament-M (NF-M), and NeuN. In a different study,
when human DPSCs were transplanted into the avian em-
bryo in vivo, DPSCs exhibited extended processes and dem-
onstrated positive staining for both early and mature neuronal
markers, b-III tubulin and NF-M, respectively.51
In contrast, NSCs stained positive for both Nestin and
Map2 before and after culture, although differences in in-
tensity were observed. The fluorescence intensity of these
markers was reversed at day 10, being Map2 expression
higher than Nestin. As mentioned previously, spinal cord
cultures with transplanted NSCs showed the presence of cell
aggregates after several days in culture, suggesting cell
proliferation. As cells differentiate, their rate of proliferation
usually decreases. Since NSCs were still proliferative within
the tissue explants, and cells showed Nestin expression after
the culture period, this suggests that these neural cells were
not completely committed to the differentiation process.
The method described in this article provides the base for
further development of more complex scaffolds for the
treatment of SCI. Since this is a complex tissue and align-
ment of axons should be closely controlled, the scaffold
needs to meet specific requirements for its successful use.
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